Status:
COMPLETED
Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
University Ghent
Conditions:
Hemodialysis
Coagulation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To avoid clotting during extracorporeal treatment, an anticoagulant is added to the circuit, resulting in an increased risk for bleeding complications. In addition, there is evidence that a substantia...
Detailed Description
This single centre, randomized cross-over study includes twenty stable chronic nocturnal hemodialysis patients with no coagulation disorder, active inflammation or chronic cumarin-derived medication. ...
Eligibility Criteria
Inclusion
- 18 years or older
- experienced stable dialysis sessions during the last 4 weeks
- nocturnal in-centre hemodialysis
- well functioning vascular access
Exclusion
- known coagulation disorder
- active inflammation
- malignancy
- no coumarin-derived medication
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05204810
Start Date
February 1 2022
End Date
April 1 2022
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital - Nephrology
Ghent, Belgium